Hospital
The Board of Trustees of the University of Illinois
The Board of Trustees of the University of Illinois was paid $2.40M by Medicaid between Jan 2018 and Sep 2020, across 69 billing codes. Its largest line is 87389, Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies — 25% of everything it billed.
33Billing provider infoTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
CHICAGO, IL 60612
CHICAGO, IL 60612
33aNPI1861431751assigned 06/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.40M
24GClaims145,585
24DCodes billed69
24AFirst – last monthJan 2018 – Sep 2020
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#14 of 129
Median peer was paid$547K
This provider vs. median4.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,553 | $479K | |
| 2019 | 84,967 | $1.40M | |
| 2020 | 33,065 | $528K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 25% | 7,867 | 2,385 | $601K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 17% | 14,550 | 3,868 | $417K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 17% | 14,519 | 3,866 | $415K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4.5% | 5,189 | 1,801 | $109K |
| 80053 | Comprehensive metabolic panel | 4.4% | 12,487 | 4,958 | $107K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.1% | 6,648 | 2,542 | $99K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.1% | 2,475 | 901 | $97K |
| 86780 | 3.5% | 9,391 | 2,608 | $85K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 12,962 | 5,048 | $53K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.9% | 6,312 | 2,266 | $46K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.5% | 861 | 392 | $36K |
| 80061 | Lipid panel | 1.3% | 7,361 | 3,125 | $32K |
57 more codes
| 86803 | 1.3% | 2,176 | $31K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.2% | 1,150 | $28K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,884 | $22K |
| 87088 | <1% | 2,238 | $20K | |
| 87522 | Neg quan hep c or qual rna | <1% | 358 | $18K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,581 | $16K |
| 82607 | <1% | 1,550 | $16K | |
| 83655 | <1% | 1,155 | $13K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 35 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,509 | $10K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 303 | $9K |
| 84439 | <1% | 1,505 | $9K | |
| 87340 | <1% | 1,046 | $9K | |
| 81001 | <1% | 4,166 | $8K | |
| 85027 | <1% | 1,841 | $7K | |
| 87205 | <1% | 2,428 | $6K | |
| 87186 | <1% | 650 | $6K | |
| 87081 | <1% | 1,226 | $6K | |
| 88142 | <1% | 1,882 | $5K | |
| 84702 | <1% | 601 | $4K | |
| 87653 | <1% | 95 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 40 | $4K |
| 83550 | <1% | 573 | $3K | |
| 80164 | <1% | 346 | $3K | |
| 87102 | <1% | 694 | $3K | |
| 81003 | <1% | 1,864 | $3K | |
| 82728 | <1% | 499 | $3K | |
| 80076 | <1% | 418 | $3K | |
| 83540 | <1% | 632 | $3K | |
| 85610 | <1% | 713 | $2K | |
| 83735 | <1% | 439 | $2K | |
| 82043 | <1% | 547 | $2K | |
| 82746 | <1% | 187 | $2K | |
| 86593 | <1% | 792 | $2K | |
| 85018 | <1% | 866 | $1K | |
| 80074 | <1% | 49 | $1K | |
| 86762 | <1% | 249 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 39 | $1K |
| 87486 | <1% | 35 | $980.32 | |
| 87581 | <1% | 35 | $980.32 | |
| 84146 | <1% | 74 | $927.26 | |
| 83690 | <1% | 124 | $752.10 | |
| 82950 | <1% | 202 | $720.40 | |
| 82150 | <1% | 123 | $695.52 | |
| 84481 | <1% | 106 | $622.71 | |
| 86850 | <1% | 199 | $599.47 | |
| 85652 | <1% | 362 | $553.35 | |
| 82270 | <1% | 230 | $530.20 | |
| 86901 | <1% | 201 | $476.38 | |
| 86900 | <1% | 238 | $470.59 | |
| 87147 | <1% | 114 | $407.41 | |
| 83880 | <1% | 26 | $363.90 | |
| 86592 | <1% | 95 | $161.14 | |
| 87077 | <1% | 348 | $154.98 | |
| 85014 | <1% | 78 | $119.78 | |
| 85045 | <1% | 29 | $61.20 | |
| 84550 | <1% | 18 | $25.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAPPEL, LAURENCE (CHIEF FINANCIAL OFFICER)
Parent organizationTHE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS